Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Neurosurg. 2016 May 20;126(3):782–795. doi: 10.3171/2016.3.JNS152699

Fig. 10.

Fig. 10

The effects of AcSDKP on the expression of TGF-β1 and NFkB one day after TBI. Protein levels of TGF-β1 and NFkB were measured by Western blot analysis in the injured cortical tissue (A). Bar graphs (B, C) show that AcSDKP treatment significantly reduced the expression of TGF-β1 and NFkB one day after TBI. There were 3 rats per group.